Your Location:
Home >
Browse articles >
Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways
COMMENTARY | Updated:2025-12-13
    • Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways

    • “In the field of xxx, expert xx has made significant research progress. They established the xx system/explored the xx topic/verified the xx conjecture, offering solutions to tackle xx problems and paving the way for future research in xx.”
    • Mabel L. Cummins , Grace Delmonte , Skylar Wechsler , Joseph J. Schlesinger
    • Military Medical Research Vol. 12, Issue 4, Pages: 633-635(2025)
    • DOI: 10.1186/s40779-024-00513-y     

      CLC:

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

48

Views

19

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy
Better therapy for combat injury
Effects of interleukin-1α on platelet-derived growth factor release from bovine cerebral microvascular endothelial cells
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

Related Author

Yang Cao
Dong-Dong Sun
Xuan Zhang
Xiao-Ming Gu
Cong-Ye Li
Xiao Zhang
Hao Wang
Lei Xin

Related Institution

Department of Cardiology, Xijing Hospital, Air Force Medical University
Department of Basic Medicine, Air Force Medical University
Department of Physiology and Pathophysiology, Air Force Medical University
Institute for Hospital Management Research, Chinese PLA General Hospital
Department of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research, Albert Einstein College of Medicine